Reply to Kulić, Ž. Comment on “Subhadra et al. Significant Broad-Spectrum Antiviral Activity of Bi121 against Different Variants of SARS-CoV-2. <i>Viruses</i> 2023, <i>15</i>, 1299”
Bobban Subhadra,
Ragini Agrawal,
Virender Kumar Pal,
Agnes-Laurence Chenine,
Jeffy George Mattathil,
Amit Singh
Affiliations
Bobban Subhadra
Biom Pharmaceutical Corporation, 2203 Industrial Blvd, Sarasota, FL 34234, USA
Ragini Agrawal
Department of Microbiology and Cell Biology, Center for Infectious Disease Research, Indian Institute of Science (IISc), CV Raman Ave., Bengaluru 560012, India
Virender Kumar Pal
Department of Microbiology and Cell Biology, Center for Infectious Disease Research, Indian Institute of Science (IISc), CV Raman Ave., Bengaluru 560012, India
Agnes-Laurence Chenine
Integrated BioTherapeutics Inc., 4 Research Court, Suite 300, Rockville, MD 20850, USA
Jeffy George Mattathil
Integrated BioTherapeutics Inc., 4 Research Court, Suite 300, Rockville, MD 20850, USA
Amit Singh
Department of Microbiology and Cell Biology, Center for Infectious Disease Research, Indian Institute of Science (IISc), CV Raman Ave., Bengaluru 560012, India
